Sofosvel is the world's first generic oral medicine of Sofosbuvir 400mg & Velpatasvir 100mg launched by Beacon Pharmaceuticals Limited, Bangladesh. Which is used for pan-genotypic Chronic Hepatitis C treatment. Patients are curing quickly by taking this medication than other Hepatitis C medication.
Sofosvel is the global first generic oral tablet for pan-genotypic Chronic Hepatitis C treatment. This combination (Sofosbuvir 400 mg + Valpatasvir 100 mg) drug has been approved by US FDA & European Commission for treatment of patients with all genotypic Chronic Hepatitis C virus infection.
Sofosvel is used without cirrhosis or with compensated cirrhosis, and patients with advanced cirrhosis (Decompensated).
Developed and Managed by Infocom Network Private Limited.